New insights into glioma classification based on isocitrate dehydrogenase 1 and 2 gene status

Ichiyo Shibahara, Yukihiko Sonoda, Masayuki Kanamori, Ryuta Saito, Toshihiro Kumabe, Teiji Tominaga

研究成果: Article

7 引用 (Scopus)

抜粋

In glioma, mutations in the isocitrate dehydrogenase 1 and 2 (IDH1/2) genes have been receiving attention. IDH1/2 mutations are frequently found in grade II and III gliomas. These genetic alterations occur very early in gliomagenesis and strongly predict favorable outcome in patients with high-grade gliomas. Despite the evolution of studies on this topic, the underlying mechanism of the IDH1/2 mutations remains unknown. Here, we briefly review the current knowledge of IDH1/2 and discuss molecular diagnostics based on IDH1/2 gene status.

元の言語English
ページ(範囲)203-208
ページ数6
ジャーナルBrain Tumor Pathology
28
発行部数3
DOI
出版物ステータスPublished - 2011 7

ASJC Scopus subject areas

  • Oncology
  • Clinical Neurology
  • Cancer Research

フィンガープリント New insights into glioma classification based on isocitrate dehydrogenase 1 and 2 gene status' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

  • これを引用